Navigation Links
400,000 Patients Is The Latest Estimate Of Those Needlessly Dying Due To Medical Errors, And Twice As Many As Any Previous Estimate
Date:10/24/2013

Greenville, SC (PRWEB) October 24, 2013

Institute of Medicine To Err Is Human (http://is.gd/2MSBhR) raised national awareness of the tragic rate of needless hospital deaths annually in 2000. The basis of 98,000 annual needless hospital deaths used in To Err Is Human had resulted from four years of research in New York state hospitals ending in 1990.

Ten years after To Err Is Human Sully Sullenberger, Hero on the Hudson, (http://is.gd/26uxXj) estimated that there were 200,000 preventable deaths each year in our hospitals, and that is like having 20 Boeing 747 airliners going down each week.

Now John T. James, PhD in Journal of Patient Safety, September 2013 (http://is.gd/GzKOg3) offers a much higher estimate of annual deaths due to medical errors. Using Global Trigger Tools James estimates, “…the true number of premature deaths associated with preventable harm to patients was estimated at more than 400,000 per year. Serious harm seems to be 10 to 20 fold more common than lethal harm.”

In Find The Black Box (http://is.gd/UK4Uk0) Williams identifies the two fundamentals of all medical care that have always been ignored, or more probably unrecognized in all of the efforts to improve the quality of healthcare and patient safety; all medical care is local and states license doctors.

Those two fundamental facts of all patient care were never recognized in To Err Is Human, and have never been recognized in the voluminous quality of healthcare literature since. As a result, the current rate of needless hospital deaths has at least doubled that original 1990 estimate, and according to James, perhaps has quadrupled, thus easily demonstrating that efforts to date have been drastically ineffective.

Worst still, twenty three years after that original estimate of annual needless hospital deaths our nation’s healthcare system must continue to rely upon highly speculative estimates due to a complete lack of any ability to obtain a far more precise count of how many patients are dying in our nation’s hospitals during any definitive period of time.

Williams contends that the annual rate of needless hospital deaths is far greater now than estimated two decades ago primarily because those two fundamentals of all medical care have been ignored, or more probably unrecognized. Find The Black Box offers a solution to the needless hospital death dilemma.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11257814.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioNeutral Group Receives $400,000 in Equity Financing
2. Mold and Leaks on Roofs Expected to Cost Fillmore Middle School $400,000, My Cleaning Products Recommends a Product That Could Cut Mold Treatment Expenses by $1,000
3. Theravalues Confirms Beneficial Effects of Theracurmin™ on Diastolic Function in Hypertensive Patients
4. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
5. New Subanalyses of RE-LY® Trial Evaluate PRADAXA in Subsets of Patients with Non-Valvular Atrial Fibrillation
6. Clionsky Neuro Systems (CNS-Neuro) Announces Publication of Study Finding Elderly Patients Unable to Recognize Their Memory Loss
7. S*BIOs Novel JAK2 Inhibitor Pacritinib (SB1518) and Histone Deacetylase Inhibitor Pracinostat (SB939) Demonstrate Promising Activity in Phase 2 Studies for Patients with Myelofibrosis (MF)
8. Candelis and Microsoft Team Up to Empower Patients
9. Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
10. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
11. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
(Date:6/23/2016)... 2016  Amgen (NASDAQ: AMGN ) today ... life sciences incubator to accelerate the development of ... space at QB3@953 was created to help high-potential life ... many early stage organizations - access to laboratory infrastructure. ... launched two "Amgen Golden Ticket" awards, providing each winner ...
(Date:6/22/2016)... Research and Markets has announced the addition of the ... The global biomarkers market ... 2013. The market is expected to grow at a five-year compound ... from $50.6 billion in 2015 to $96.6 billion in 2020. ... (2015 to 2020) are discussed. As well, new products approved in ...
Breaking Biology Technology:
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):